Health – tobacco

Impact assessment: E-cigarettes: a developing public health consensus, 2016
Joint statement on e-cigarettes by Public Health England and other UK public health organisations | PHE, UK

Nicotine without smoke: Tobacco harm reduction, 2016
A new report released today from the Royal College of Physicians, ‘Nicotine without smoke: tobacco harm reduction’ concludes that e-cigarettes are likely to be beneficial to UK public health. Smokers can therefore be reassured and encouraged to use them, and the public can be reassured that e-cigarettes are much safer than smoking | RCP, UK

The Stolen years: how smoking disproportionately harms those with mental health conditions
People with mental health conditions die on average 10-20 years earlier than the general population and smoking is the single largest factor in this shocking difference. Around one third of adult tobacco consumption is by people with a current mental health condition with smoking rates more than double that of the general population | ASH, UK

Evidence update on e-cigarettes, 2015
Following two previous reports produced for Public Health England (PHE) on ecigarettes (EC) in 2014, this report updates and expands on the evidence of the implications of EC for public health. It covers the EC policy framework, the prevalence of EC use, knowledge and attitudes towards EC, impact of EC use on smoking behaviour, as well as examining recent safety issues and nicotine content, emissions and delivery | PHE, UK

Smokeless tobacco and public health – a global perspective (Global Tobacco Surveillance System Data), 2014
A new report from the National Cancer Institute (NCI) and the Centers for Disease Control and Prevention (CDC), Smokeless Tobacco and Public Health: A Global Perspective, provides a snapshot of the current science on smokeless tobacco (ST) use, characteristics of smokeless tobacco products, and policy strategies. The report also identifies research gaps and makes recommendations around enhancing research, surveillance, and capacity building for policy impact | Center for Disease Control, USA